Clinical Trial

Motivational Interviewing at Intake vs Intake as Usual on Client Engagement in Addiction Treatment

Recruiting
View on ClinicalTrials.gov →
Summary
This K23 study is an effectiveness-implementation hybrid type I design to determine the effectiveness of Motivational Interviewing at Intake (MII), relative to intake-as-usual on client engagement and mechanisms of engagement among adults seeking outpatient addiction treatment. We also will obtain personnel feedback on the feasibility of implementing MII into standard practice by having personnel from the addiction treatment study sites complete implementation climate measures before Motivational Interviewing (MI) training and post-clinical trial, as well as an individual interview on implementation feasibility post-trial.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2022-08-02; most recent amendment 2026-03-05.
Trial Details
NCT Number NCT05489068
Lead Sponsor University of New Mexico
Collaborators: National Institute on Drug Abuse (NIDA)
Conditions Substance-Related Disorders, Treatment Adherence
Enrollment 150 participants
Start Date 2022-03-16
Primary Completion 2026-10-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-09